Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
National Institutes of Health · PA-25-253 · Research funding opportunity
Overview
Supports early-stage ideas with potential to advance population-based cancer prevention and control. Projects may develop new methods, models or interventions addressing cancer risk, screening, behaviour or healthcare delivery.
Funding amount
Up to USD 275000 in direct costs over 2 years; maximum USD 200000 per year
Eligibility
Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply.
Other deadlines
Next new-application deadline: 16 October 2026. Next renewal/resubmission/revision deadline, where permitted: 16 November 2026. Submit by 17:00 local time of the applicant organisation. Call expiration: 8 September 2028. This is separate from the application deadline.